TrialDiabetologia2005

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.

P D Home et al.PubMed ↗Publisher ↗

No numbers read from the abstract.